Viewing Study NCT02393157

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:00 PM
Ignite Modification Date: 2026-02-20 @ 2:45 AM
Study NCT ID: NCT02393157
Status: RECRUITING
Last Update Posted: 2025-08-08
First Post: 2015-03-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL
Sponsor: New York Medical College
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Hodgkin Lymphoma View
None Burkitt Lymphoma View
None Diffuse Large B-Cell Lymphoma View
None Primary Mediastinal B-cell Lymphoma View
None CD20+ Lymphoblastic Lymphoma View
None Follicular Lymphoma, Grade III View
Keywords: